1-2 of 2
Heidi McIntyre, BS
Close
Sort by
Journal Articles

Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study

Hartmut Döhner, MD, John F Seymour, MBBS, FRACP, PhD, Aleksandra Butrym, MD, Agnieszka Wierzbowska, MD PhD, Dominik Selleslag, MD, Jun Ho Jang, MD, James D Cavenagh, MD, Rajat Kumar, FRCPC, Andre C Schuh, MD FRCPC, Anna Candoni, MD, Christian Récher, MDPhD, Irwindeep Sandhu, MD FRCPC, Teresa Bernal del Castillo, MD, Haifa Kathrin Al-Ali, MD, Giovanni Martinelli, MD, Jose Falantes, MD, Richard M. Stone, MD, Mark D. Minden, MD PhD, Heidi McIntyre, BS, Stephen Songer, PharmD, Lela M. Lucy, MS, CL Beach, PharmD, Hervé Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 621.
https://doi.org/10.1182/blood.V124.21.621.621
Published: 2014
Journal Articles

Azacitidine (AZA) Versus Conventional Care Regimens (CCR) in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (>30% Bone Marrow Blasts) with Morphologic Dysplastic Changes: A Subgroup Analysis of the AZA-AML-001 Trial

John F Seymour, MBBS, FRACP, PhD, Hartmut Döhner, MD, Aleksandra Butrym, MD, Agnieszka Wierzbowska, MD PhD, Dominik Selleslag, MD, Jun Ho Jang, MD, James D Cavenagh, MD, Rajat Kumar, MD, Andre C. Schuh, MD FRCPC, Anna Candoni, MD, Christian Récher, MDPhD, Irwindeep Sandhu, MD FRCPC, Teresa Bernal del Castillo, MD, Haifa Kathrin Al-Ali, MD, Giovanni Martinelli, MD, Jose Falantes, MD, Richard M Stone, Mark D. Minden, MD PhD, Heidi McIntyre, BS, Stephen Songer, PharmD, Lela M. Lucy, MS, CL Beach, PharmD, Hervé Dombret, MD
Journal: Blood
Blood (2014) 124 (21): 10.
https://doi.org/10.1182/blood.V124.21.10.10
Published: 2014